Want to track SGMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sagimet Biosciences Inc. (SGMT) Statistics
Valuation metrics
Market Cap 233.29M
Enterprise value 193.77M
Trailing P/E (ttm) -5.24
Forward P/E -3.19
PEG ratio -0.2
Price/Sales (ttm) -
Price/Book (mrq) 2.25
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.2
Overview
Shares outstanding 32.52M
Float 29.98M
Shares short 3.23M
% Held by insiders 0.06%
% Held by institutions 0.45%
Average volume (10 days) 1.21M
Average volume (90 days) 2.88M
Price summary
52-Week low 4.5
52-Week high 10.46
Beta 3.21
50-Day moving average 7.01
200-Day moving average 6.1
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.4%
Return on equity -0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -51.04M
Diluted EPS (ttm) -1.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 113.12M
Total cash per share (mrq) 3.21
Total debt (mrq) 78K
Total Debt/Equity (mrq) 0
Current ratio (mrq) 20.34%
Book value per share (mrq) 3.15
Cash Flow
Cash flow statement -45.65M
Levered free cash flow (LFCF) -30.22M
